Geode Capital Management, LLC Nuvectis Pharma, Inc. Transaction History
Geode Capital Management, LLC
- $1.39 Trillion
- Q2 2025
A detailed history of Geode Capital Management, LLC transactions in Nuvectis Pharma, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 285,332 shares of NVCT stock, worth $1.95 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
285,332
Previous 135,333
110.84%
Holding current value
$1.95 Million
Previous $1.32 Million
61.2%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding NVCT
# of Institutions
48Shares Held
3.2MCall Options Held
44.5KPut Options Held
50.1K-
Vanguard Group Inc Valley Forge, PA667KShares$4.55 Million0.0% of portfolio
-
Ronit Capital LLP563KShares$3.84 Million5.37% of portfolio
-
Iridian Asset Management LLC373KShares$2.55 Million1.01% of portfolio
-
Baldwin Brothers LLC350KShares$2.39 Million0.19% of portfolio
-
State Street Corp Boston, MA114KShares$775,7440.0% of portfolio
About Nuvectis Pharma, Inc.
- Ticker NVCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,642,500
- Market Cap $100M
- Description
- Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src...